Roger Perlmutter, former Merck R&D head, becomes CEO of super-microscopy startup
Eikon Therapeutics is using microscope technology to pinpoint the location of individual molecules within cells as a way to invent new drugs.
Read The StoryBiotech
Inside the discoveries, personalities, and deals driving drug development. Sign up for The Readout newsletter to get the latest on biotech delivered to your inbox. And subscribe to STAT+ to access daily, market-moving coverage of the biotech sector — from startup funding to clinical trial readouts
Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims
The long wait for Cel-Sci to finally admit its cancer drug doesn’t work
Biotech venture capitalists have more money than ever to invest. What could possibly go wrong?
Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine
All Coverage
advertisement
